Skip to content
Wednesday, August 26, 2026
1 WOMEN'S HEALTHWOMEN'S & REPRODUCTIVE HEALTH

Women's Health Trial Tracker — 2010

RecordRecord DateVuga GroupChange StatusRecency DaysPublic Significance Score
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers01/20/2010INTERVENTIONALunchanged6,062.850
Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)02/08/2010INTERVENTIONALunchanged6,043.850
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer02/12/2010INTERVENTIONALunchanged6,039.850
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer03/05/2010INTERVENTIONALunchanged6,018.850
Extending the National Health Service (NHS) Breast Screening Age Range03/05/2010INTERVENTIONALunchanged6,018.850
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer03/05/2010INTERVENTIONALunchanged6,018.850
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer03/26/2010INTERVENTIONALunchanged5,997.850
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer05/05/2010INTERVENTIONALunchanged5,957.850
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life05/31/2010OBSERVATIONALunchanged5,931.850
Excision Followed by Radiofrequency Ablation for Breast Cancer06/29/2010INTERVENTIONALunchanged5,902.850
Teriparatide (PTH) and Bone Strength in Postmenopausal Women07/01/2010OBSERVATIONALunchanged5,900.850
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer07/22/2010INTERVENTIONALunchanged5,879.850
Predictive Assays In Cervix Cancer08/13/2010INTERVENTIONALunchanged5,857.850
Rehabilitation of Cognitive Changes in Breast Cancer Survivors08/16/2010INTERVENTIONALunchanged5,854.850
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors09/09/2010INTERVENTIONALunchanged5,830.850
Relaxation for Women With Breast Cancer Undergoing Radiotherapy09/16/2010INTERVENTIONALunchanged5,823.850
Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer09/16/2010INTERVENTIONALunchanged5,823.850
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer10/29/2010INTERVENTIONALunchanged5,780.850
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer11/19/2010INTERVENTIONALunchanged5,759.850
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer11/22/2010INTERVENTIONALunchanged5,756.850
National Pregnancy Registry for Psychiatric Medications11/23/2010OBSERVATIONALunchanged5,755.850
Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer11/24/2010INTERVENTIONALunchanged5,754.850
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer12/24/2010INTERVENTIONALunchanged5,724.850